B M Owen1, D Eccleston, I N Ferrier, A H Young. 1. Stanley Foundation Research Centre, Psychiatry Research Laboratories, University of Newcastle Medical School, Newcastle upon Tyne, UK.
Abstract
OBJECTIVE: Interleukin-1beta (IL-1beta) is released as part of the acute phase immune response and can directly stimulate the release of corticotrophin-releasing hormone and thus induce hypothalamic pituitary adrenal axis hyperactivity. Major depression has been shown to be accompanied by both an acute phase immune response, including raised IL-1beta production and hypothalamic pituitary adrenal axis hyperactivity. In this study the possible role of IL-1beta in major depression and postviral depression was investigated. METHOD: Plasma IL-1beta levels were measured in four groups; patients suffering from postviral depression (n= 17), patients with major depression (n = 20), subjects who were postviral and euthymic (n= 12) and normal controls (n = 20). RESULTS: IL-1beta serum concentrations were significantly elevated in both groups of depressed patients compared to controls. The serum concentrations of IL-1beta were higher in the postviral group than in the major depression group; this difference was not significant. CONCLUSION: These data confirm previous suggestions of elevated IL-1beta levels in major depression and postviral depression. IL-1beta is known to induce depressive symptoms as well as sickness behaviour and may contribute to the hypothalamic pituitary adrenal axis hyperactivity found in mood disorders.
OBJECTIVE:Interleukin-1beta (IL-1beta) is released as part of the acute phase immune response and can directly stimulate the release of corticotrophin-releasing hormone and thus induce hypothalamic pituitary adrenal axis hyperactivity. Major depression has been shown to be accompanied by both an acute phase immune response, including raised IL-1beta production and hypothalamic pituitary adrenal axis hyperactivity. In this study the possible role of IL-1beta in major depression and postviral depression was investigated. METHOD: Plasma IL-1beta levels were measured in four groups; patients suffering from postviral depression (n= 17), patients with major depression (n = 20), subjects who were postviral and euthymic (n= 12) and normal controls (n = 20). RESULTS:IL-1beta serum concentrations were significantly elevated in both groups of depressedpatients compared to controls. The serum concentrations of IL-1beta were higher in the postviral group than in the major depression group; this difference was not significant. CONCLUSION: These data confirm previous suggestions of elevated IL-1beta levels in major depression and postviral depression. IL-1beta is known to induce depressive symptoms as well as sickness behaviour and may contribute to the hypothalamic pituitary adrenal axis hyperactivity found in mood disorders.
Authors: Bárbara Tagliari; Ana Paula Tagliari; Felipe Schmitz; Aline A da Cunha; Carla Dalmaz; Angela T S Wyse Journal: Neurochem Res Date: 2010-12-24 Impact factor: 3.996
Authors: Clare J Wilhelm; Aaron Murphy-Crews; Daniel J Menasco; Marilyn S Huckans; Jennifer M Loftis Journal: Neuropharmacology Date: 2011-08-04 Impact factor: 5.250
Authors: Anastacia Y Kudinova; Terrence Deak; Cara M Hueston; John E McGeary; Valerie S Knopik; Rohan H C Palmer; Brandon E Gibb Journal: J Abnorm Psychol Date: 2016-04-07
Authors: K Winkley; H Sallis; D Kariyawasam; L H Leelarathna; T Chalder; M E Edmonds; D Stahl; K Ismail Journal: Diabetologia Date: 2011-11-06 Impact factor: 10.122